Retinal detachment (RD), uncomplicated by proliferative vitreoretinopathy (PVR) was primarily treated with scleral buckling, the current flavor being vitrectomy. Vitrectomy necessarily requires the use of a tamponading agent, most common being gas in RDs without PVR. The disadvantage of gas tamponade of an inferior RD is the need to maintain a face-down/lateral position for a period of time, the other being delayed visual rehabilitation while waiting for the gas to absorb. In patients who cannot maintain the prescribed position may need silicone oil tamponade, with its attendant disadvantages of another surgery to remove the oil, silicone oil glaucoma, and delayed visual rehabilitation. Pneumoretinopexy is a simpler procedure with the caveat being its inability to treat retinal breaks in the inferior 4 o'clock hours.
The authors in this study report the use of fibrin glue for temporary closure of the retinal break. [1] The idea of using glue to close the retinal break is not novel, the earliest report dating back to the 1950s and 1960s. [2, 3] Renewed interest in using glue to close the retinal break is possibly linked to recent trend of RD primarily being treated with vitrectomy than with scleral buckling. Glues are unlikely to reach the retina or stay on its surface in a non-vitrectomized eye.
Using a glue to close the retinal break offers some advantages: 1. The absence of tamponade induced refractive change can result in earlier visual rehabilitation 2. Post-operative positioning is avoided thus allowing one to treat patients who cannot maintain position for systemic reasons. Maintaining post-operative position can be difficult even for able bodied individuals and avoidance of the same using glue would be welcome 3. Additional surgery to remove silicone oil would be avoided 4. The closure of the break completely with the glue will also prevent migration of the retinal pigment epithelium in to the vitreous cavity in the post-operative period; this can result in lesser incidence of PVR, but this of course remains to be proven in larger, long-term studies 5. Lesser incidence of cataract in the absence of a long-term intravitreal tamponade.
While the technique described by the authors sounds promising, we need to exercise caution as the study has been performed on a small sample size with a short follow-up. The limitations of this technique as mentioned by the authors and as I see it are:
1. It has been used to treat simple cases without PVR, the ones that can also be managed by scleral buckling. Scleral buckling also would allow earlier rehabilitation, no additional surgery to remove the tamponade or increased risk of cataract. Of course scleral buckling would induce a refractive error. While it remains to be seen if it can be used in eyes without PVR, I would think the role of glue obviating the need for long-term tamponade would be rather limited in these cases. Precise application of the glue over multiple breaks or retinectomy edges would be challenging and if there were residual folds over which the glue flows, it can result in a retino-retinal adhesion as well 2. Visualization through air can be tricky and to precisely place the tiny amounts of two components of the glue at the break without letting it spread to adjacent areas/posterior pole can be a challenge. Coloring the glue may aid better visualization and its placement at the break 3. While fibrin sealant has been used in few cases of optic disc pit maculopathy and morning glory associated RD, long-term toxicity/result of using intravitreal glue are yet to be understood [4, 5] 4. Anaphylactic reaction to aprotinin in the fibrin sealant has rarely been reported (when used elsewhere in the body), the risk being higher with repeat exposure [6] 5. Considering that the glue is produced out of human biological components, there is a rare possibility of transmission of slow viral diseases 6. We need to factor in the additional cost of the glue into the surgical cost 7. A thorough vitrectomy would be necessary as the presence of vitreous gel may not allow the glue to occlude the break adequately 8. A thorough fluid air exchange would also be preferable to disallow slippage of the glue before adhesion.
We look forward to further elucidation by the authors and others by means of larger controlled studies of the use of glue to seal the retinal breaks. There would be a learning curve, but then it would be an useful technique in at least a subset of patients with simple rhegmatogenous RD. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. 
C o m m e n t a r y : F i b r i n g l u e i n rhegmatogenous retinal detachment repair-Are we there yet?
Tissue adhesives have a long history of use in ophthalmology.
The concept of using fibrin as a biologic adhesive was introduced nearly a century ago. And its use in ophthalmic surgery dates back to the early 1940s. [1] Both the synthetic tissue adhesives such as cyanoacrylate glue and the biologic adhesives such as the fibrin glue have found extensive application in ophthalmology. They are mainly used in corneal and ocular surface surgeries as adhesives, for wound apposition and as structural fillers. They are also being increasingly used in squint surgeries, lid and adnexal surgeries, glaucoma surgeries, and so on.
However, their use in vitreoretinal surgery has been limited to conjunctival closure, and sclerotomy closure. Of late, it gained wide application as an adjunct to fixate the haptics of a scleral-fixated intraocular lens (IOL). But intraocular use of tissue adhesives has been limited so far to only a few animal studies and a few case reports. [2] [3] [4] [5] The first report of an animal study using cyanoacrylate glue for the closure of retinal breaks appeared in 1986, and although it produced strong adhesion between the retina and the retinal pigment epithelium (RPE), it also led to localized retinal necrosis around the adhesive causing full thickness retinal breaks or retinal atrophy. [6] Fibrin glue, on the contrary, is biologically derived, and the commercially available product manufactured meticulously to exclude any possible contamination or infective organism inclusion has been found to be safe for human use. It has two components: a fibrinogen component and a thrombin component. When mixed together, the thrombin activates the fibrinogen leading to formation of fibrin which on polymerization leads to long fibrin strands causing adhesion. Nasaduke and Peyman [2] in 1986 and later Coleman et al. [3] in 1988 reported the use of fibrin as sealant for retinal breaks in animal eyes. They found it nontoxic, noninflammatory, and effective in sealing breaks.
Over 30 years have passed but fibrin glue has not got any current application in vitreoretinal surgery. Barring a few case reports for macular hole closure [4] and management of optic pit associated detachment, [5] it has not been used as a sealant for retinal breaks. This requires some pondering over.
In this issue, Al Sabti et al.
[6] report their experience of using fibrin glue along with laser photocoagulation to close the retinal breaks. In the five patients that they have reported, the authors could achieve closure of breaks in all with no tamponade and no postoperative positioning. As the fibrin glue causes instantaneous adhesion, no tamponade is needed. The obvious advantages of this procedure are that the complications associated with tamponade with either gas or silicone oil, such as cataract, secondary glaucoma, and corneal decompensation, are avoided. Many patients find maintaining the prone position quite challenging and thus would prefer this option. Also, a second surgery for silicone oil removal is not needed. The authors also claim that there can be early visual recovery with this technique. Avoidance of tamponade and the postoperative positioning are two huge advantages of this technique.
However, one needs to look at the possible unfavorable consequences also. Fibrin glue has been known to produce epiretinal proliferation.
[7] The glue can be seen subretinally around the retinal break on histopathological exam.
[8] There is a possibility of the glue migrating subfoveally leading to subnormal visual recovery. The possibility of excess contraction of the glue leading to proliferative vitreoretinopathy (PVR) changes cannot be ruled out. Also, it remains to be seen whether the glue can be effective in sealing large retinal breaks, multiple breaks in different quadrants, or breaks in the presence of preexisting PVR. In case of residual vitreous which might be adherent to the breaks, the fibrin glue might lead to firm vitreous adhesions and contraction which might precipitate unfavorable complications. Furthermore, the toxicity and/or possibility of infection needs to be extensively studied. The authors have used laser photocoagulation for creating retinal adhesion, and the glue seems to have been used as a barrier to fluid and a cover for the exposed RPE.
Although this small series shows the proof of concept that fibrin glue can work well as a sealant for retinal breaks without the need for tamponade or head position, we are still a long way off from replacing our existing time-tested methods of retinal reattachment repair with fibrin glue. It requires a larger study with proper controls and a long follow-up to identify potential problems and drawbacks and to confirm its usefulness.
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